Retina
273-288 of 341
Amy S. Babiuch, MD
Caroline Baumal, MD
David Eichenbaum, MD
Roger A. Goldberg, MD, MBA
Nancy M. Holekamp, MD
- CME/CE Broadcast Replay
VBS Fellows Foray 2020: Cases and Real-World Treatment Strategies - Part 2
1.00 creditAnton Orlin, MD
Will Parke, MD
Aleksandra V. Rachitskaya, MD
Camila Ventura, MD, PhD
BY: Amy S. Babiuch, MD
Caroline Baumal, MD
David Eichenbaum, MD
Roger A. Goldberg, MD, MBA
Nancy M. Holekamp, MD
Aleksandra V. Rachitskaya, MD
Jorge A. Fortun, MD
Mitul Mehta, MD
Hemang K. Pandya, MD
Veeral Sheth, MD
Lejla Vajzovic, MD
Jeremy Wolfe, MD
Aleksandra V. Rachitskaya, MD
Jorge A. Fortun, MD
Mitul Mehta, MD
Hemang K. Pandya, MD
Veeral Sheth, MD
Lejla Vajzovic, MD
Jeremy Wolfe, MD
- CME/CE
Current and Future Treatments in Age-Related Macular Degeneration: 2019 Year in Review
1.00 creditCharles C. Wykoff, MD, PhD
Audina Berrocal, MD
Geeta A. Lalwani, MD
Andrew Moshfeghi, MD, MBA
Anton Orlin, MD
Yoshihiro Yonekawa, MD
Aleksandra V. Rachitskaya, MD
Jorge A. Fortun, MD
Mitul Mehta, MD
Hemang K. Pandya, MD
Veeral Sheth, MD
Lejla Vajzovic, MD
Jeremy Wolfe, MD
Arshad M. Khanani, MD, MA
David Boyer, MD
Allen Ho, MD
Nancy Holekamp, MD
Jorge Fortun, MD
Mitul Mehta, MD
Hemang Pandya, MD
Veeral Sheth, MD
Arshad M. Khanani, MD, MA
Nancy Holekamp, MD
Jonathan Prenner, MD
Michael Singer, MD
- CME/CE Broadcast Replay
What's Changing: Market Access Challenges with Anti-VEGF Therapies - Webcast
1.00 creditNathan Steinle, MD
Winston Wong, PharmD
Sean Goodale, CPA, MBA
- CME/CE Broadcast Replay
Advances in Gene Therapies for Retinal Disorders: Individualized Management of Patients
1.25 creditsAllen C. Ho, MD
Robert Avery, MD
Pravin U. Dugel, MD
Jeffrey S. Heier, MD
- CME/CE
Addressing Barriers to Patient Care: Market Access Challenges With Anti-VEGF Therapies
1.00 creditNathtan Steinle, MD
Sean Goodale, CPA, MBA
Winston Wong, PharmD
Thomas A. Albini, MD
Nathan M. Radcliffe, MD
Aleksandra V. Rachitskaya, MD
Will Parke, MD
Anton Orlin, MD
Camila Ventura, MD, PhD
